An overview of the c-MET signaling pathway

Cited by papers we hold 18

• Pre-metastatic niche: formation, characteristics and therapeutic implication · 2024
  No notice
• Recent advances in non-small cell lung cancer targeted therapy; an update review · 2023
  No notice
• Structural basis of the activation of c-MET receptor · 2021
  No notice
• Antibody–drug conjugates in solid tumors: a look into novel targets · 2021
  No notice
• Small molecules in targeted cancer therapy: advances, challenges, and future perspectives · 2021
  No notice
• Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics · 2020
  No notice
• Overview of current targeted therapy in gallbladder cancer · 2020
  No notice
• Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020) · 2020
  No notice
• Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies · 2019
  No notice
• Trends and Challenges in Tumor Anti-Angiogenic Therapies · 2019
  No notice
• MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer · 2019
  No notice
• PROTACs: great opportunities for academia and industry · 2019
  No notice
• Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment · 2019
  No notice
• Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p · 2019
  No notice
• A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy · 2017
  No notice
• Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation · 2017
  No notice
• Retinal and choroidal angiogenesis: a review of new targets · 2017
  No notice
• Tetraspanins Function as Regulators of Cellular Signaling · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.